MEC combines a global network of physician scientists with experienced investors, company builders, and operators. They focus on investing in company creation, seed, and Series A opportunities that use technology and novel approaches to transform the life sciences industry. MEC deploys precision capital to nurture and advance precision health innovations that solve complex medical problems. They believe that the post Covid-19 era will bring about a golden age of innovation in the life sciences space. With their unique combination of expertise and network, MEC aims to be a leading venture firm in the life sciences industry.